Literature DB >> 27839805

Review of early hospitalisation after percutaneous coronary intervention.

Chun Shing Kwok1, William Hulme2, Ivan Olier3, Eric Holroyd4, Mamas A Mamas5.   

Abstract

BACKGROUND: Percutaneous coronary intervention (PCI) is the most common modality of revascularization in patients with coronary artery disease. Understanding the readmission rates and reasons for readmission after PCI is important because readmissions are a quality of care indicator, in addition to being a burden to patients and healthcare services.
METHODS: A literature review was performed. Relevant studies are described by narrative synthesis with the use of tables to summarize study results.
RESULTS: Data suggests that 30-day readmissions are not uncommon. The rate of readmission after PCI is highly influenced by the cohort and the healthcare system studied, with 30-day readmission rates reported to be between 4.7-% and 15.6%. Studies consistently report that a majority of readmissions within 30days are due to a cardiac-related disorders or complication-related disorders. Female sex, peripheral vascular disease, diabetes mellitus, renal failure and non-elective PCI are predictive of readmission. Studies also suggest that there is greater risk of mortality among patients who are readmitted compared to those who are not readmitted.
CONCLUSION: Readmission after PCI is common and its rate is highly influenced by the type of cohort studied. There is clear evidence that majority of readmissions within 30days are cardiac related. While there are many predictors of readmission following PCI, it is not known whether targeting patients with modifiable predictors could prevent or reduce the rates of readmission.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Coronary angioplasty; Coronary revascularization; Hospitalisation; Percutaneous coronary intervention; Readmission

Mesh:

Year:  2016        PMID: 27839805     DOI: 10.1016/j.ijcard.2016.11.050

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.

Authors:  Chun Shing Kwok; Binita Shah; Jassim Al-Suwaidi; David L Fischman; Lene Holmvang; Chadi Alraies; Rodrigo Bagur; Vinayak Nagaraja; Muhammad Rashid; Mohamed Mohamed; Glen P Martin; Evan Kontopantelis; Tim Kinnaird; Mamas Mamas
Journal:  JACC Cardiovasc Interv       Date:  2019-03-27       Impact factor: 11.195

2.  The burden of major adverse cardiac events in patients with coronary artery disease.

Authors:  I-Ting Tsai; Chao-Ping Wang; Yung-Chuan Lu; Wei-Chin Hung; Cheng-Ching Wu; Li-Fen Lu; Fu-Mei Chung; Chia-Chang Hsu; Yau-Jiunn Lee; Teng-Hung Yu
Journal:  BMC Cardiovasc Disord       Date:  2017-01-04       Impact factor: 2.298

3.  Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.

Authors:  Li-Jun Zhou; Xue-Ying Chen; Shui-Ping Liu; Lin-Lin Zhang; Ya-Nan Xu; Pan-Wei Mu; Deng-Feng Geng; Zhi Tan
Journal:  J Am Heart Assoc       Date:  2017-07-27       Impact factor: 5.501

4.  The association between CRP / Albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction.

Authors:  Uğur Aksu; Oktay Gulcu; Emrah Aksakal; Kamuran Kalkan; Mustafa Öztürk; Ali Fuat Korkmaz; Abdulkadir Uslu; Selami Demirelli
Journal:  J Clin Lab Anal       Date:  2019-02-08       Impact factor: 2.352

5.  Clinical and Economic Burden of Hyperkalemia: A Nationwide Hospital-Based Cohort Study in Japan.

Authors:  Eiichiro Kanda; Naoki Kashihara; Shun Kohsaka; Suguru Okami; Toshitaka Yajima
Journal:  Kidney Med       Date:  2020-10-17

6.  Percutaneous coronary intervention and 30-day unplanned readmission with chest pain in the United States (Nationwide Readmissions Database).

Authors:  RobertA Sykes; Mohamed O Mohamed; Chun Shing Kwok; Mamas A Mamas; Colin Berry
Journal:  Clin Cardiol       Date:  2021-02-16       Impact factor: 3.287

7.  Platelet-Mimicking Therapeutic System for Noninvasive Mitigation of the Progression of Atherosclerotic Plaques.

Authors:  Yi Ma; Yuxuan Ma; Mengqiu Gao; Zhihao Han; Wen Jiang; Yueqing Gu; Yi Liu
Journal:  Adv Sci (Weinh)       Date:  2021-02-18       Impact factor: 16.806

8.  LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vulnerable atherosclerotic plaques.

Authors:  Jingxin Hou; Jun Zhou; Meiqi Chang; Guangcheng Bao; Jie Xu; Man Ye; Yixin Zhong; Shuling Liu; Junrui Wang; Wei Zhang; Haitao Ran; Zhigang Wang; Yu Chen; Dajing Guo
Journal:  Bioact Mater       Date:  2022-03-03

9.  Causes and predictors of early readmission after percutaneous coronary intervention among patients discharged on oral anticoagulant therapy.

Authors:  Mahesh K Vidula; Cian P McCarthy; Neel M Butala; Kevin F Kennedy; Jason H Wasfy; Robert W Yeh; Eric A Secemsky
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.